New mineralocorticoid receptor antagonists: update on their use in chronic kidney disease and heart failure-Reference-Cited by-同舟云学术

New mineralocorticoid receptor antagonists: update on their use in chronic kidney disease and heart failure

Published:2019-04-15 Issue:1 Volume:33 Page:37-48
ISSN:1121-8428
Container-title:Journal of Nephrology
language:en
Short-container-title:J Nephrol

Author:

Capelli Irene,Gasperoni Lorenzo,Ruggeri Marco,Donati Gabriele,Baraldi Olga,Sorrenti Giovanni,Caletti Maria Turchese,Aiello Valeria,Cianciolo Giuseppe,La Manna Gaetano^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Nephrology

Link

http://link.springer.com/content/pdf/10.1007/s40620-019-00600-7.pdf

Reference56 articles.

1. Funder JW (2005) Mineralocorticoid receptors: distribution and activation. Heart Fail Rev 10(1):15–22. https://doi.org/10.1007/s10741-005-2344-2

2. Funder JW (2005) Mineralocorticoid-receptor blockade, hypertension and heart failure. Nat Clin Pract Endocrinol Metab 1(1):4–5. https://doi.org/10.1038/ncpendmet0016

3. Funder JW (2010) Minireview: aldosterone and mineralocorticoid receptors: past, present, and future. Endocrinology 151(11):5098–5102. https://doi.org/10.1210/en.2010-0465

4. Vashistha V, Lee M, Wu YL, Kaur S, Ovbiagele B (2016) Low glomerular filtration rate and risk of myocardial infarction: a systematic review and meta-analysis. Int J Cardiol 223:401–409 https://doi.org/10.1016/j.ijcard.2016.07.175

5. Bansal N, Hsu CY, Go AS (2014) Intersection of cardiovascular disease and kidney disease: atrial fibrillation. Curr Opin Nephrol Hypertens 23(3):275–282. https://doi.org/10.1097/01.mnh.0000444820.80249.56

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Management of Primary Aldosteronism: An Update;Hypertension;2024-09

2. Efficacy and safety of nonsteroidal mineralocorticoid receptor antagonists for renal and cardiovascular outcomes in patients with chronic kidney disease: a meta-analysis of randomized clinical trials;Frontiers in Pharmacology;2024-02-27

3. Gene expression analysis to identify mechanisms underlying improvement of myocardial fibrosis by finerenone in SHR;Biochemical Pharmacology;2024-02

4. Single-cell transcriptomics and chromatin accessibility profiling elucidate the kidney-protective mechanism of mineralocorticoid receptor antagonists;Journal of Clinical Investigation;2024-01-02

5. New possibilities of nephroprotection in type 2 diabetes using finerenone Consensus of the board of experts;Diabetes Obesity Metabolic Syndrome;2023-10-27